本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioNexus Gene Lab Corp.

1.33
-0.0596-4.29%
成交量:8,176
成交额:1.05万
市值:390.14万
市盈率:-1.07
高:1.33
开:1.33
低:1.22
收:1.39
52周最高:5.89
52周最低:1.07
股本:293.34万
流通股本:188.10万
量比:0.54
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-1.2467
每股收益(LYR):-1.6075
净资产收益率:-33.66%
总资产收益率:-18.99%
市净率:0.50
市盈率(LYR):-0.83

数据加载中...

2023/10/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/09

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2020/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]